Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor α and systemic immune activation

N. M. Moutsopoulos, G. E. Katsifis, N. Angelov, R. A. Leakan, V. Sankar, S. Pillemer, S. M. Wahl

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Fingerprint Dive into the research topics of 'Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor α and systemic immune activation'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences